[{"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-001", "question": "A 68-year-old man with a history of severe COPD (FEV1 35% predicted) and chronic hypercapnia (baseline PaCO2 55 mmHg) presents with acute-on-chronic hypercapnic respiratory failure requiring non-invasive ventilation. After 48 hours of improvement, his arterial blood gas shows pH 7.36, PaCO2 48 mmHg, PaO2 85 mmHg on 2 L/min nasal cannula. He is alert and comfortable. The next most appropriate step in management is:", "options": ["Gradually wean and discontinue supplemental oxygen to target a PaO2 of 55-60 mmHg", "Continue current oxygen therapy and plan for discharge home with home oxygen", "Increase oxygen flow to achieve a PaO2 > 88 mmHg", "Obtain a venous blood gas to confirm the arterial values", "Initiate acetazolamide 250 mg twice daily to accelerate renal compensation"], "answer": "A", "answer_index": 0, "explanation": "In patients with chronic hypercapnia, the hypoxic drive is a primary respiratory stimulus. Over-oxygenation can suppress this drive, leading to worsening hypercapnia and acidosis. The target PaO2 is 55-60 mmHg or SpO2 88-92%, which provides adequate oxygenation while minimizing the risk of CO2 retention. Increasing oxygen (C) is dangerous, and acetazolamide (E) is not indicated in acute-on-chronic respiratory failure as it can worsen acidosis by inhibiting compensatory metabolic alkalosis.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer (A) is not the single best answer. Key stem clues: Patient with severe COPD, chronic hypercapnia, acute-on-chronic respiratory failure now improved, alert and comfortable on 2L/min O2 with pH 7.36, PaCO2 48 mmHg, PaO2 85 mmHg. Main logical issue: While answer A reflects traditional teaching about avoiding over-oxygenation in COPD, current guidelines prioritize maintaining SpO2 88-92% (PaO2 ~60 mmHg) in stable patients. However, this patient's PaO2 of 85 mmHg is already above target, so weaning oxygen (A) is reasonable. But answer B (continue current therapy and plan discharge) is equally defensible since the patient is stable, comfortable, and improved. Multiple answers defensible (M) also applies. Medical accuracy issue: The explanation perpetuates the oversimplified 'hypoxic drive' theory, which is controversial and not evidence-based for guiding oxygen therapy. Minimal fix: Specify that the patient has concerning symptoms (e.g., dyspnea, fatigue) that would make weaning oxygen (A) clearly indicated, or state he's ready for discharge planning (making B clearly best).\",\n    \"medical_accuracy_score\": 3,\n    \"logical_validity\": false,\n    \"logical_false_reason\": \"K\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer (A) is not the single best answer. Key stem clues: Patient with severe COPD, chronic hypercapnia, acute-on-chronic respiratory failure now improved, alert and comfortable on 2L/min O2 with pH 7.36, PaCO2 48 mmHg, PaO2 85 mmHg. Main logical issue: While answer A reflects traditional teaching about avoiding over-oxygenation in COPD, current guidelines prioritize maintaining SpO2 88-92% (PaO2 ~60 mmHg) in stable patients. However, this patient's PaO2 of 85 mmHg is already above target, so weaning oxygen (A) is reasonable. But answer B (continue current therapy and plan discharge) is equally defensible since the patient is stable, comfortable, and improved. Multiple answers defensible (M) also applies. Medical accuracy issue: The explanation perpetuates the oversimplified 'hypoxic drive' theory, which is controversial and not evidence-based for guiding oxygen therapy. Minimal fix: Specify that the patient has concerning symptoms (e.g., dyspnea, fatigue) that would make weaning oxygen (A) clearly indicated, or state he's ready for discharge planning (making B clearly best).", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-002", "question": "A 45-year-old woman with a history of recurrent calcium oxalate kidney stones presents with acute pancreatitis. Lipase is 1200 U/L, calcium 11.8 mg/dL, PTH 85 pg/mL (normal 10-65). She is not on lithium or thiazides. A pancreatic protocol CT shows diffuse gland enlargement but no necrosis or ductal dilation. The most likely underlying etiology of her pancreatitis is:", "options": ["Primary hyperparathyroidism due to parathyroid adenoma", "Autoimmune pancreatitis (IgG4-related disease)", "Hereditary pancreatitis due to PRSS1 mutation", "Hypertriglyceridemia-induced pancreatitis", "Pancreatitis secondary to a gastrinoma (Zollinger-Ellison syndrome)"], "answer": "A", "answer_index": 0, "explanation": "The triad of hypercalcemia, elevated PTH, and recurrent calcium oxalate stones is classic for primary hyperparathyroidism. Hypercalcemia is a known, though uncommon, cause of pancreatitis. The elevated PTH confirms primary hyperparathyroidism, not secondary causes. While hypertriglyceridemia (D) can cause pancreatitis, it doesn't explain the hypercalcemia and elevated PTH. Gastrinoma (E) is associated with ulcers and diarrhea, not typically hypercalcemia and stones.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Acute pancreatitis with hypercalcemia (11.8 mg/dL), elevated PTH (85 pg/mL), recurrent calcium oxalate stones, no lithium/thiazides. Main logical issue: The keyed answer (A) is incorrect because primary hyperparathyroidism is not the most likely etiology of pancreatitis in this patient. Hypercalcemia from hyperparathyroidism is a rare cause of pancreatitis, while hypertriglyceridemia is a common cause and frequently coexists with hyperparathyroidism. The vignette lacks triglyceride levels, making D equally plausible. Main medical accuracy issue: Overstating hyperparathyroidism as the 'most likely' etiology ignores the higher prevalence and stronger association of hypertriglyceridemia with pancreatitis. Minimal fix: Add serum triglyceride level >1000 mg/dL to make D uniquely best, or specify normal triglycerides to support A.\",\n    \"medical_accuracy_score\": 2,\n    \"logical_validity\": false,\n    \"logical_false_reason\": \"K\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Acute pancreatitis with hypercalcemia (11.8 mg/dL), elevated PTH (85 pg/mL), recurrent calcium oxalate stones, no lithium/thiazides. Main logical issue: The keyed answer (A) is incorrect because primary hyperparathyroidism is not the most likely etiology of pancreatitis in this patient. Hypercalcemia from hyperparathyroidism is a rare cause of pancreatitis, while hypertriglyceridemia is a common cause and frequently coexists with hyperparathyroidism. The vignette lacks triglyceride levels, making D equally plausible. Main medical accuracy issue: Overstating hyperparathyroidism as the 'most likely' etiology ignores the higher prevalence and stronger association of hypertriglyceridemia with pancreatitis. Minimal fix: Add serum triglyceride level >1000 mg/dL to make D uniquely best, or specify normal triglycerides to support A.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-003", "question": "A 32-year-old woman presents with 3 weeks of progressive dyspnea and fatigue. Echocardiogram shows a large pericardial effusion with diastolic right atrial and right ventricular collapse. Right heart catheterization reveals equalization of diastolic pressures (RA 18, RV 18, PA 18/20, PCWP 18 mmHg). After pericardiocentesis of 800 mL of serosanguinous fluid, hemodynamics improve. Cytology is negative. Two days later, she develops recurrent dyspnea. Repeat echo shows reaccumulation of the effusion. The most appropriate definitive management is:", "options": ["Repeat pericardiocentesis and initiate colchicine", "Surgical creation of a pericardial window via subxiphoid approach", "Initiation of high-dose prednisone for suspected autoimmune pericarditis", "Pericardiectomy via left thoracotomy", "Intrapericardial instillation of bleomycin"], "answer": "B", "answer_index": 1, "explanation": "Recurrent symptomatic pericardial effusion with tamponade physiology, especially when cytology is negative (ruling out malignancy requiring specific therapy), is a clear indication for a definitive surgical procedure to prevent reaccumulation. A surgical pericardial window (subxiphoid or video-assisted) allows for drainage and biopsy. Pericardiectomy (D) is reserved for constrictive pericarditis. Steroids (C) are for inflammatory causes but are not definitive for recurrent effusion. Intrapericardial chemotherapy (E) is for malignant effusions.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: recurrent large pericardial effusion with tamponade physiology (diastolic collapse, equalization of pressures) after initial drainage, negative cytology, and rapid reaccumulation within days. This defines recurrent, symptomatic effusion requiring definitive drainage. Surgical pericardial window (B) is standard definitive management to prevent reaccumulation and obtain tissue for diagnosis. Pericardiocentesis alone (A) is temporizing; steroids (C) are for inflammatory causes but not definitive for recurrent effusion; pericardiectomy (D) is for constriction; intrapericardial chemotherapy (E) is for malignant effusions. No logical contradictions; key matches standard guidelines. Medical accuracy is sound. Minimal fix: none needed; item is clear and accurate.\",\n    \"medical_accuracy_score\": 5,\n    \"logical_validity\": true,\n    \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: recurrent large pericardial effusion with tamponade physiology (diastolic collapse, equalization of pressures) after initial drainage, negative cytology, and rapid reaccumulation within days. This defines recurrent, symptomatic effusion requiring definitive drainage. Surgical pericardial window (B) is standard definitive management to prevent reaccumulation and obtain tissue for diagnosis. Pericardiocentesis alone (A) is temporizing; steroids (C) are for inflammatory causes but not definitive for recurrent effusion; pericardiectomy (D) is for constriction; intrapericardial chemotherapy (E) is for malignant effusions. No logical contradictions; key matches standard guidelines. Medical accuracy is sound. Minimal fix: none needed; item is clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-004", "question": "A 70-year-old man with atrial fibrillation on apixaban (non-valvular) presents with acute onset of right-sided weakness and aphasia 4 hours after symptom onset. NIHSS is 15. CT head shows no hemorrhage. He is not a candidate for IV tPA due to anticoagulation. CT angiography shows a left M1 MCA occlusion. The most appropriate acute intervention is:", "options": ["Administer IV tPA after checking an INR and anti-Xa level", "Proceed directly to mechanical thrombectomy without thrombolysis", "Administer IV protamine to reverse apixaban, then give IV tPA", "Administer andexanet alfa, then give IV tPA", "Initiate IV heparin drip and observe for neurological improvement"], "answer": "B", "answer_index": 1, "explanation": "For patients with acute ischemic stroke and large vessel occlusion (LVO) who are not candidates for IV tPA, mechanical thrombectomy is the standard of care if performed within 24 hours of last known well and meeting other criteria (like NIHSS ≥6). Direct thrombectomy is non-inferior to bridging therapy (tPA + thrombectomy). Reversing anticoagulation to give tPA (C, D) delays definitive therapy and adds bleeding risk. Giving tPA on top of therapeutic anticoagulation (A) is contraindicated.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: acute ischemic stroke (NIHSS 15, left M1 occlusion), presentation within 4 hours, contraindication to IV tPA due to therapeutic apixaban, and no hemorrhage on CT. This defines a patient eligible for mechanical thrombectomy. The logic is sound: for large vessel occlusion with a tPA contraindication, proceeding directly to thrombectomy is standard. Main logical issue: None. Main medical accuracy issue: Minor nuance—the 24-hour window for thrombectomy depends on advanced imaging selection, but the core teaching point is accurate. Minimal fix: None required for core validity; could add 'within 6 hours of symptom onset' to the stem to align with most straightforward trial criteria, but the implied eligibility is clear.\",\n  \"medical_accuracy_score\": 4,\n  \"logical_validity\": true,\n  \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: acute ischemic stroke (NIHSS 15, left M1 occlusion), presentation within 4 hours, contraindication to IV tPA due to therapeutic apixaban, and no hemorrhage on CT. This defines a patient eligible for mechanical thrombectomy. The logic is sound: for large vessel occlusion with a tPA contraindication, proceeding directly to thrombectomy is standard. Main logical issue: None. Main medical accuracy issue: Minor nuance—the 24-hour window for thrombectomy depends on advanced imaging selection, but the core teaching point is accurate. Minimal fix: None required for core validity; could add 'within 6 hours of symptom onset' to the stem to align with most straightforward trial criteria, but the implied eligibility is clear.", "medical_accuracy_score": 4, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-005", "question": "A 55-year-old man with alcoholic cirrhosis (Child-Pugh B) is admitted with hepatic encephalopathy. He is started on lactulose. On day 3, he develops acute kidney injury. Serum sodium is 122 mEq/L (down from 128 on admission), creatinine 2.4 mg/dL (baseline 0.9), and he is clinically envolemic. Urine sodium is <10 mEq/L, urine osmolality 550 mOsm/kg. The most likely cause of his hyponatremia is:", "options": ["Syndrome of inappropriate antidiuretic hormone secretion (SIADH)", "Acute tubular necrosis from sepsis", "Hepatorenal syndrome type 1", "Pseudohyponatremia from hypertriglyceridemia", "Hyponatremia due to lactulose-induced diarrhea"], "answer": "E", "answer_index": 4, "explanation": "Lactulose causes an osmotic diarrhea, leading to loss of sodium and water, but relatively more water loss, resulting in hypertonic hyponatremia. The clinical picture (envolemic, high urine osmolality, low urine sodium) is consistent with volume depletion from GI losses, not SIADH (which has inappropriately high urine sodium). Hepatorenal syndrome (C) is characterized by low urine sodium but typically occurs in the setting of avid sodium retention and ascites, not acute diarrhea. ATN (B) would have high urine sodium.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 1 column 1 (char 0)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-006", "question": "A 28-year-old pregnant woman at 32 weeks gestation is admitted for severe preeclampsia with BP 170/110 mmHg. She is started on IV magnesium sulfate for seizure prophylaxis and IV labetalol for blood pressure control. One hour after initiation of magnesium, she becomes somnolent, with loss of deep tendon reflexes. Respiratory rate is 8 breaths/min. Serum magnesium level is 9.2 mg/dL. After securing the airway, the most specific immediate treatment is:", "options": ["IV administration of 10% calcium gluconate 1 gram over 10 minutes", "IV administration of furosemide 40 mg to enhance renal excretion", "Immediate hemodialysis", "Discontinuation of magnesium sulfate and administration of IV levothyroxine", "IV administration of pyridostigmine 2 mg"], "answer": "A", "answer_index": 0, "explanation": "Calcium gluconate is the direct antagonist to the life-threatening cardiac and neuromuscular effects of hypermagnesemia. It stabilizes cardiac membranes and reverses respiratory depression caused by magnesium. Furosemide (B) promotes excretion but is not immediate. Dialysis (C) is for severe cases with renal failure but is not the first step after airway management. Pyridostigmine (E) is for myasthenia, not magnesium toxicity.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: severe preeclampsia on IV magnesium sulfate, somnolence, areflexia, respiratory depression (8/min), serum magnesium 9.2 mg/dL (toxic level). After airway secured, the most specific immediate treatment is calcium gluconate, a direct physiologic antagonist. Main logical issue: None; stem clearly describes magnesium toxicity and asks for most specific immediate treatment after airway management. Main medical accuracy issue: None; calcium gluconate is standard for acute severe hypermagnesemia. Minimal fix: None needed; item is clear and accurate. Alternatives: B (furosemide) is slower excretion aid, not immediate antagonist; C (dialysis) is for refractory cases/renal failure; D (levothyroxine) irrelevant; E (pyridostigmine) for myasthenia, not magnesium toxicity.\",\n    \"medical_accuracy_score\": 5,\n    \"logical_validity\": true,\n    \"logical_false_reason\": \"T\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: severe preeclampsia on IV magnesium sulfate, somnolence, areflexia, respiratory depression (8/min), serum magnesium 9.2 mg/dL (toxic level). After airway secured, the most specific immediate treatment is calcium gluconate, a direct physiologic antagonist. Main logical issue: None; stem clearly describes magnesium toxicity and asks for most specific immediate treatment after airway management. Main medical accuracy issue: None; calcium gluconate is standard for acute severe hypermagnesemia. Minimal fix: None needed; item is clear and accurate. Alternatives: B (furosemide) is slower excretion aid, not immediate antagonist; C (dialysis) is for refractory cases/renal failure; D (levothyroxine) irrelevant; E (pyridostigmine) for myasthenia, not magnesium toxicity.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-007", "question": "A 62-year-old man with a history of asbestos exposure 30 years ago presents with unilateral right-sided pleural effusion. Thoracentesis reveals exudative fluid (by Light's criteria) with cytology positive for adenocarcinoma. PET-CT shows FDG-avid right pleural thickening and effusion, with no other distant metastases. The next best step in management is:", "options": ["Systemic chemotherapy with platinum-pemetrexed", "Pleurodesis followed by systemic chemotherapy", "Extrapleural pneumonectomy", "Pleurectomy/decortication followed by adjuvant chemoradiation", "Immunotherapy with pembrolizumab as first-line treatment"], "answer": "D", "answer_index": 3, "explanation": "This describes a likely diagnosis of malignant pleural mesothelioma (given asbestos exposure, unilateral effusion, pleural thickening). For resectable disease (stage I-III) in a fit patient, the standard of care is maximal cytoreductive surgery (pleurectomy/decortication) followed by adjuvant chemotherapy and possibly radiation. Extrapleural pneumonectomy (C) is a more radical, less commonly performed option. Systemic therapy alone (A) is for unresectable disease. Pleurodesis (B) is palliative.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer D is not the current standard of care for this presentation. Key stem clues: 62-year-old man, asbestos exposure 30 years ago, unilateral right pleural effusion, exudative fluid with adenocarcinoma cytology, PET-CT shows FDG-avid right pleural thickening/effusion without distant metastases. Main logical issue: The vignette describes adenocarcinoma-positive cytology, which definitively indicates metastatic adenocarcinoma (likely lung primary) rather than mesothelioma. For stage IV adenocarcinoma with malignant pleural effusion (M1a), current NCCN/ASCO guidelines recommend systemic therapy (platinum-pemetrexed with immunotherapy for non-squamous NSCLC) as first-line, not surgery. Main medical accuracy issue: Treating this as resectable mesothelioma contradicts the adenocarcinoma cytology finding. Minimal fix: Change cytology finding to 'mesothelioma cells' or 'atypical mesothelial cells' to make D defensible, or change key to A with appropriate systemic therapy.\",\n    \"medical_accuracy_score\": 2,\n    \"logical_validity\": false,\n    \"logical_false_reason\": \"K\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer D is not the current standard of care for this presentation. Key stem clues: 62-year-old man, asbestos exposure 30 years ago, unilateral right pleural effusion, exudative fluid with adenocarcinoma cytology, PET-CT shows FDG-avid right pleural thickening/effusion without distant metastases. Main logical issue: The vignette describes adenocarcinoma-positive cytology, which definitively indicates metastatic adenocarcinoma (likely lung primary) rather than mesothelioma. For stage IV adenocarcinoma with malignant pleural effusion (M1a), current NCCN/ASCO guidelines recommend systemic therapy (platinum-pemetrexed with immunotherapy for non-squamous NSCLC) as first-line, not surgery. Main medical accuracy issue: Treating this as resectable mesothelioma contradicts the adenocarcinoma cytology finding. Minimal fix: Change cytology finding to 'mesothelioma cells' or 'atypical mesothelial cells' to make D defensible, or change key to A with appropriate systemic therapy.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-008", "question": "A 40-year-old woman presents with palpitations, heat intolerance, and weight loss. TSH is <0.01 mIU/L, free T4 is 3.2 ng/dL (high). Thyroid ultrasound shows a 2 cm hypoechoic nodule in the right lobe. Radioactive iodine uptake scan shows diffusely increased uptake (45% at 24 hours) with a photopenic area corresponding to the nodule. The most likely diagnosis is:", "options": ["Graves' disease with a coexisting cold nodule", "Toxic multinodular goiter", "Subacute thyroiditis", "Factitious thyrotoxicosis", "Marine-Lenhart syndrome (Graves' disease with a functioning nodule)"], "answer": "A", "answer_index": 0, "explanation": "The diffusely increased uptake is diagnostic of Graves' disease. The photopenic ('cold') nodule within an area of diffusely high uptake indicates a non-functioning nodule, which raises concern for malignancy and requires FNA biopsy. Marine-Lenhart syndrome (E) is Graves' with a *functioning* (hot) nodule. Toxic MNG (B) would show multiple areas of increased uptake. Subacute thyroiditis (C) shows very low uptake.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - a unique best answer exists but the provided key (A) is not it. Key stem clues: Diffusely increased RAIU (45% at 24h) is classic for Graves' disease. The photopenic ('cold') nodule within diffusely high uptake is the critical finding. The most likely diagnosis is Marine-Lenhart syndrome (E), which is Graves' disease with a coexisting autonomously functioning ('hot') nodule that appears photopenic on scan due to suppression of surrounding tissue. Option A describes a cold (non-functioning) nodule, which would not explain the diffusely increased uptake pattern. Main logical issue: Key mismatch despite clear discriminators. Medical accuracy: The explanation incorrectly states Marine-Lenhart involves a functioning nodule appearing hot (not photopenic). Minimal fix: Change key to E and clarify in rationale that in Marine-Lenhart, the hyperfunctioning nodule appears photopenic due to suppressed surrounding tissue.\",\n    \"medical_accuracy_score\": 3,\n    \"logical_validity\": false,\n    \"logical_false_reason\": \"K\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - a unique best answer exists but the provided key (A) is not it. Key stem clues: Diffusely increased RAIU (45% at 24h) is classic for Graves' disease. The photopenic ('cold') nodule within diffusely high uptake is the critical finding. The most likely diagnosis is Marine-Lenhart syndrome (E), which is Graves' disease with a coexisting autonomously functioning ('hot') nodule that appears photopenic on scan due to suppression of surrounding tissue. Option A describes a cold (non-functioning) nodule, which would not explain the diffusely increased uptake pattern. Main logical issue: Key mismatch despite clear discriminators. Medical accuracy: The explanation incorrectly states Marine-Lenhart involves a functioning nodule appearing hot (not photopenic). Minimal fix: Change key to E and clarify in rationale that in Marine-Lenhart, the hyperfunctioning nodule appears photopenic due to suppressed surrounding tissue.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-009", "question": "A 50-year-old man with diabetes mellitus and hypertension is found to have a serum potassium of 6.8 mEq/L on routine labs. He is asymptomatic. ECG shows peaked T waves. He is given IV calcium gluconate, insulin/dextrose, and albuterol. His potassium decreases to 6.0 mEq/L. Renal function is normal. Further workup reveals a low serum aldosterone and elevated plasma renin activity. The most likely cause of his hyperkalemia is:", "options": ["Type 4 renal tubular acidosis (hyporeninemic hypoaldosteronism)", "Addison's disease", "Gordon's syndrome (pseudohypoaldosteronism type II)", "Spironolactone use", "Rhabdomyolysis"], "answer": "C", "answer_index": 2, "explanation": "Gordon's syndrome (familial hyperkalemic hypertension) is characterized by hyperkalemia, hypertension, normal GFR, metabolic acidosis, and *suppressed* renin but *normal or high* aldosterone. The key here is the elevated renin, which rules out hyporeninemic hypoaldosteronism (A, which has low renin and low aldosterone) and points to a primary renal defect in potassium excretion. Addison's (B) has low aldosterone and high renin but also has hyponatremia and hypotension.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 1 column 1 (char 0)"}, {"quiz_id": "20251205T082731900Z_deepseek-v3.2_seed123", "question_id": "20251205T082731900Z_deepseek-v3.2_seed123-010", "question": "A 65-year-old man with a mechanical aortic valve (On-X) on warfarin presents with a transient ischemic attack. INR on presentation is 1.8 (target 2.5-3.5). He has no bleeding history. The most appropriate adjustment to his antithrombotic regimen is:", "options": ["Increase warfarin dose to achieve INR 2.5-3.5; add aspirin 81 mg daily", "Increase warfarin dose to achieve INR 2.5-3.5; no aspirin needed", "Switch to apixaban 5 mg twice daily", "Add clopidogrel 75 mg daily to current warfarin therapy", "Discontinue warfarin and initiate dual antiplatelet therapy with aspirin and clopidogrel"], "answer": "A", "answer_index": 0, "explanation": "For a mechanical aortic valve, the standard of care is warfarin with a target INR of 2.5-3.5. In patients who have a thromboembolic event despite therapeutic INR, adding aspirin 75-100 mg is recommended. Since his INR was subtherapeutic at the time of the TIA, the first step is to optimize INR control. However, given the event, adding low-dose aspirin is now indicated based on PROACT and other trials. Direct oral anticoagulants (C) are contraindicated in mechanical valves. Dual antiplatelet therapy (E) is inferior to warfarin for valve protection.", "generator_model": "deepseek-v3.2", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "```json\n{\n    \"analysis\": \"Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: mechanical aortic valve (On-X), warfarin therapy, TIA event, subtherapeutic INR (1.8 vs target 2.5-3.5), no bleeding history. The clinical problem asks for appropriate antithrombotic adjustment after TIA with subtherapeutic INR. The unique best answer is A because: (1) mechanical valves require warfarin with INR 2.5-3.5, (2) subtherapeutic INR must first be corrected, (3) adding aspirin after thromboembolic event on mechanical valve is guideline-supported (ACC/AHA). B misses aspirin addition indicated after event. C (DOAC) contraindicated in mechanical valves. D adds clopidogrel without correcting INR first. E abandons essential warfarin. No contradictions or missing details. Medical accuracy aligns with current guidelines. Minimal fix: none needed; item is clear and accurate.\",\n    \"medical_accuracy_score\": 5,\n    \"logical_validity\": true,\n    \"logical_false_reason\": \"T\"\n}\n```", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict on keyed answer: Correct best. Key stem clues: mechanical aortic valve (On-X), warfarin therapy, TIA event, subtherapeutic INR (1.8 vs target 2.5-3.5), no bleeding history. The clinical problem asks for appropriate antithrombotic adjustment after TIA with subtherapeutic INR. The unique best answer is A because: (1) mechanical valves require warfarin with INR 2.5-3.5, (2) subtherapeutic INR must first be corrected, (3) adding aspirin after thromboembolic event on mechanical valve is guideline-supported (ACC/AHA). B misses aspirin addition indicated after event. C (DOAC) contraindicated in mechanical valves. D adds clopidogrel without correcting INR first. E abandons essential warfarin. No contradictions or missing details. Medical accuracy aligns with current guidelines. Minimal fix: none needed; item is clear and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}]